Skip to main content
Premium Trial:

Request an Annual Quote

NextGen, Paragon to Co-market Genomic, Proteomic Services

NEW YORK (GenomeWeb News) - NextGen Sciences and the Baltimore, Md.-based Paragon Bioservices will co-market each others’ genomics and proteomics services, NextGen said today.
The alliance allows the companies to expand fee-for-service offerings including biomarker discovery and monitoring, functional assay development, protein production and proteomics, NextGen said.
This agreement will allow NextGen and Paragon to offer “a one stop shop” for clients’ “entire gene to protein needs,” the Cambridgeshire, UK-based company added.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.